Compound YZG-331 leverages gut microbiota to improve sleep in mouse models of insomnia
This new article publication from Acta Pharmaceutica Sinica B discusses how interactions between the investigational compound YZG-331 and the gut microbiota contribute to its sleep-promoting effects in mouse models of insomnia.
Read original article on The Medical News →Related news
-
Lower immunity after lockdown likely impacted outbreak of deadly strep A infections
United Kingdom
-
An ADHD diagnosis can be a map to guide a person through challenging territory—not to avoid it altogether
United Kingdom
-
Scientists use AI to develop bird flu vaccine that outperforms current stockpiled shot
United Kingdom
-
One gene, two paths: Opposite synaptic defects linked to same intellectual disability
United Kingdom
-
Researchers establish best methods to measure genetic variation within the body
United Kingdom
-
Health data privacy protections must extend beyond individuals, microbiome researchers argue
United Kingdom
-
Dementia with Lewy bodies: What you should know about the little‑known, progressive brain disease
United Kingdom
-
Light-based cochlear implants trigger more distinct nerve signals than electrical stimulation in gerbil study
United Kingdom